Key Takeaways
- Rural stress and down-trading define the quarter: Consolidated revenue grew modestly while gross margins contracted 280 bps as high inflation pushed rural consumers toward low-unit-price packs, compressing value-weighted volume to minus 3%.
- Category headwinds masked market share gains: Hair Oil and Oral Care categories declined 4.5% and 8% respectively, dragging Dabur's reported growth to low single digits even as the company hit its highest-ever toothpaste market share of 15.8% and became the #2 oral care player.
- Gross margin recovery is a two-quarter story: Management expects two more quarters of pain before returning to old gross margin levels, contingent on softening commodities and price increases in Hair Oils, where Dabur follows the market leader.
- E-commerce and new-age channels are scaling fast: E-commerce grew 40% and now contributes ~9% of revenue, with new product development contributing ~15% of online sales and the drinks franchise on track to reach ₹500 crores.
- What to watch next quarter: Whether rural green shoots translate into demand recovery, the pace of gross margin improvement as Hair Oil price increases land, and the initial contribution from the Badshah acquisition, consolidated from Q4.
Rural Demand & Down-Trading
- Rural slowdown persisted: High inflation, uneven monsoon distribution, and consumer down-trading continued to pressure rural markets through Q3, with the Central Region declining 3-4% due to deficient rainfall in UP and Bihar.
- Down-trading to LUPs accelerated: Low-unit-price packs grew 20-25% versus the overall business growth rate of 3-4%, as consumers shifted to ₹1, ₹2, ₹5, and ₹10 price points; this mix shift diluted margins and optically depressed reported volume.
- Smaller brands gained shelf space: Cheaper local and regional brands made inroads into rural markets because they undercut Dabur's pricing, intensifying competition at the value end.
- Green shoots appeared late in the quarter: Rural markets showed early signs of revival in November and December, and management expects the rural-urban growth gap to narrow over the next couple of quarters.
- Government support provides a floor: Management noted that government programs covering food, electricity, housing, and education for rural households create a safety net that should prevent prolonged rural distress.
Mohit Malhotra: "I don't see rural languishing beyond a point. So, I'm pretty hopeful of a rural recovery."
Category Performance & Market Share
- Toothpaste gained share in a declining category: The oral care category fell ~8%, with the market leader contributing significantly to that decline, but Dabur Red grew steadily and Meswak maintained momentum, pushing overall toothpaste share to a record 15.8% and making Dabur the #2 oral care player.
- Hair Oils held share as the category contracted: The Hair Oil category declined 4.5%, but Dabur's market share rose 70 bps to an all-time high of 16.2%; price increases lagged because Dabur follows the market leader, compressing margins in this portfolio.
- Healthcare returned to positive trajectory: After lapping two years of elevated COVID bases, the Healthcare portfolio turned positive; Digestives grew 11.2% on strong Hajmola performance, while OTC delivered double-digit growth led by Lal Tail, Honitus, and Shilajit.
- Home Care and Shampoos outperformed: Home Care grew 18% with double-digit gains across Odonil, Odomos, and Sanifresh; Shampoos grew 4% on a high base of 21% and added 40 bps of market share.
- Category dependence caps upside: Management acknowledged that with market shares in the 15-16% range, Dabur has significant headroom, but when key categories decline 5-8%, the company cannot fully isolate itself from that drag.
Mohit Malhotra: "If the category is flagging and is minus 5%, 6%, which is the case now, Hair Oil is down by 4.5%, Oral Care is down by around 8%, so we end up growing at around 3% and 4%. That's where it becomes a low single digit for us, because we are not isolated from the category growth rate."
Margins & Inflation
- Gross margin contracted 280 bps: Material inflation and currency headwinds drove the compression, though the sequential rate of contraction moderated as commodity prices began softening.
- Hair Oils remain the margin laggard: Price increases have been taken across the HPC portfolio except Hair Oils, where Dabur's follower position prevents it from leading; this segment continues to drag consolidated gross margins.
- Inflation mix is shifting: Crude and herbs are softening, but imported concentrates face inflation from rupee depreciation, and the Food & Beverage basket is seeing a pickup, which could compress food business gross margins going forward.
- Ad spend was optimized to protect the P&L: Advertising and promotion spend grew only ~2%, in line with revenue, but the mix shifted from ATL to BTL and trade promotions to defend market share without expanding the absolute spend.
- Intent is to rebalance toward brand-building: Management plans to increase ATL spending going forward, rationalize trade promotions, and return to demand generation on power brands, while holding EBITDA margins near current levels before pushing them back toward pre-COVID levels.
Mohit Malhotra: "I think there will be another 2 quarters of pain before we are able to go back to our old gross margin levels. That's my prediction. But the market situation is quite in flux and it's volatile, so one can't really comment because it's dependent on war and multiple other macro factors."
Channel & Distribution Dynamics
- E-commerce delivered standout growth: The channel grew 40% and now accounts for ~9% of total revenue; new product development contributes ~15% of online sales, with drinks, juices, baby care, and specialty toothpaste variants scaling rapidly.
- New-age channels performed well: Modern trade is expected to grow 15-20% in the coming year, supported by a new Must Stock List initiative that incentivizes last-mile salesmen to stock larger packs and premium offerings in Class II and III towns.
- Separate distribution for drinks: A dedicated distribution network is being set up for the drinks franchise, which management expects will soon become a ₹500 crore business, supported by new plants in Indore and Jammu.
- Beverages growth optically understated: Reported 3.7% growth in beverages is misleading because Diwali shifted from November to October, pulling festive-season loading into Q2; underlying momentum remains strong and the business continues to outperform the industry.
Portfolio Strategy & Premiumization
- Healthcare salience set to rise: With COVID bases normalizing post-Q4, Healthcare should return to 8-10% normalized growth, and its revenue salience is expected to move back to 31-32%, which will support overall company margins.
- Premiumization efforts are scaling in urban markets: Initiatives include organic and single-flower honey, sugar-free and Gur Chyawanprash, therapeutic hair oils, and sensitive toothpaste; e-commerce NPD contribution is higher than the company average.
- Badshah acquisition consolidates from Q4: The spices and condiments brand will be consolidated effective January 2, adding a new growth vector in the food space.
- Food business on track for ₹500 crores: Management reiterated its 3-4 year guidance for the food business, calling it well within reach, with beverages scaling from ₹200 crores toward ₹500 crores.
- New leadership for Healthcare: The ex-CEO of Himalaya joined Dabur to provide strategic impetus to the Healthcare business, signaling management's intent to accelerate this margin-accretive portfolio.
Volume Reporting & Measurement Nuance
- Reported volume decline is an accounting artifact: The mandated formula produced a value-weighted volume figure of minus 3%, but secondary sales volume in absolute eaches and tonnage actually increased by ~3 percentage points; the gap is driven by the mix shift toward low-unit-price packs and a higher food-to-healthcare ratio.
- LUP penetration is rising: Low-unit-price packs are growing at 20-25%, well ahead of the 3-4% business growth rate, indicating that penetration is increasing even as value per unit falls; this is margin-dilutive in the short term but expands the consumer base.
- Grammage reduction is industry-wide: All key players are reducing grammage to hit lower price points, and the gel toothpaste segment is showing strong growth because it is priced slightly lower than paste formats.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Gross margin recovery | Return to old gross margin levels, contingent on commodity softening and Hair Oil price increases | ~2 quarters |
| EBITDA margin trajectory | Hold margins near current levels, then push back toward pre-COVID levels; full-year FY23 anticipated down 60-70 bps vs pre-COVID | Correction in FY24 |
| Healthcare growth normalization | Return to normalized growth of 8-10% after COVID bases lapse | Post-Q4 FY23 |
| Healthcare revenue salience | Salience to move back to 31-32% of revenue | As Healthcare normalizes |
| Drinks franchise scale | Become a ₹500 crore franchise | "Very soon" |
| Food business scale | Reach ₹500 crores | 3-4 years |
| Advertising spend rebalancing | Increase ATL spending, rationalize trade spends and consumer promotions | Going forward |
| Badshah consolidation | Consolidated into Dabur financials | Q4 FY23 (effective Jan 2) |
| Rural recovery | Rural-urban growth gap to narrow; rural to return to "old glorious days" | "Couple of quarters" |
| Modern trade growth | Grow at 15-20% | Next year |
Key Metrics
| Metric | Q3 FY23 |
|---|---|
| Consolidated revenue | ₹3,000 cr+, crossed for the first time in a quarter; constant currency growth of 5.7% |
| India business revenue growth | 3.3% |
| International business revenue growth | 14% in constant currency |
| India business 3-year revenue CAGR | ~10%, with near double-digit CAGR in healthcare and HPC, mid-teens CAGR in F&B |
| Consolidated gross margin contraction | 280 bps |
| Consolidated operating margin decline | 129 bps |
| Standalone operating margin decline | 26 bps |
| Total inflation | 8.5% |
| Price increase taken | ~6.5% |
| Expected inflation going forward | ~5.5% |
| Food & Beverage business growth | 6.4% |
| HPC portfolio growth | 2.2% |
| Toothpaste portfolio growth | 3.2% |
| Toothpaste market share | 15.8%, highest ever, 80 bps ahead of erstwhile #2 player |
| Home Care growth | 18% |
| Shampoos growth | 4%, on a high base of 21% growth |
| Hair oils category decline | 4.5%; Dabur market share increased 70 bps to highest ever 16.2% |
| Digestive category growth | 11.2% |
| OTC portfolio growth | Double-digit |
| Ethical portfolio growth (ex-COVID contextual) | 7% |
| E-commerce growth | 40%; now contributes ~9% of total revenues |
| Modern trade growth | Double-digit |
| Secondary sales volume growth | ~3% |
| Value-weighted volume | minus 3% |
| LUP contribution | ~25% |
| LUP growth rate | 20–25%, compared to business growth rate of 3–4% |
| Healthcare YTD decline | ~minus 7% |
| Chyawanprash decline | minus 5% |
| Honey growth trajectory | 9% |
| Oral Care rural contribution | 40% |
| Hair Care rural contribution | ~46% |
| Full year anticipated margin vs pre-COVID | Down by ~60–70 bps |